Business
Visby Medical Tackles STI Epidemic with First At-Home FDA-Authorized PCR Test in Partnership with Google Cloud
SAN JOSE, Calif., November 12, 2025--Visby Medical today announced the national launch of the first-of-its-kind FDA-authorized at-home PCR test for sexually transmitted infections (STIs) in women, redefining how sexual health is diagnosed and treated. The palm-sized test, now available nationwide with seamless virtual care support and rapid home delivery, accurately detects three of the most common and often asymptomatic infections—chlamydia, gonorrhea, and trichomoniasis—in just 30 minutes.
About this update from Doordash, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":868,"height":200,"url":"https://media.zenfs.com/en/business-wire.com/b16f7894ca8ebb024cd32cf5d48344c0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xS7.bMFOVdTg9Hzf7rWSVA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIyMTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/b16f7894ca8ebb024cd32cf5d48344c0","width":868,"height":200},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/VxtLluYCuPt0RJ3KEuTYxA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE3MzY7aD00MDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/b16f7894ca8ebb024cd32cf5d48344c0","width":868,"height":200}},"lazy":false},{"type":"text","content":"The Company’s New Rapid Women’s Sexual Health Test is Accessible Today via Direct-to-Consumer Partnerships with Everlywell, DoorDash, and GoPuff","length":144,"tagName":"p","attribs":{}},{"type":"text","content":"SAN JOSE, Calif., November 12, 2025--(BUSINESS WIRE)--Visby Medical today announced the national launch of the first-of-its-kind FDA-authorized at-home PCR test for sexually transmitted infections (STIs) in women, redefining how sexual health is diagnosed and treated. The palm-sized test, now available nationwide with seamless virtual care support and rapid home delivery, accurately detects three of the most common and often asymptomatic infections—chlamydia, gonorrhea, and trichomoniasis—in just 30 minutes.","length":513,"tagName":"p"},{"type":"text","content":"This news comes on the heels of Visby having a long standing history of addressing healthcare epidemics in the U.S., first in 2020 with COVID-19 and now with STIs as rates continue to rise across the country. Millions of Americans still face significant barriers to convenient testing and treatment, including costs, time constraints, and concerns about privacy. According to the Office on Women’s Health, more than 9 million women in the U.S. are diagnosed with an STI each year, many without noticeable symptoms, increasing the risk of serious health complications. Left untreated, common STIs can lead to chronic pelvic pain, infertility, and life-threatening ectopic pregnancies. Visby is addressing these barriers by providing accessible, discreet, and rapid at-home care.","length":777,"tagName":"p"},{"type":"text","content":""Today m...